HomeGuides › Lot traceability
Operations

Lot traceability: answering “who received Lot X?” in minutes

By · ~7 min read · Updated August 2026

There is one question that separates a business that survives a bad batch from one that does not, and you will be asked it with no warning:

Which customers received Lot X?

If you can answer that in minutes, a supply problem is a contained, expensive inconvenience. If it takes you days, or you cannot answer at all, the only responsible move is to contact everyone who bought that product across any timeframe, which is enormously more damaging to both your finances and your reputation than the underlying problem was.

The thing that determines which situation you are in is a decision you make at inbound receiving, long before anything goes wrong.

The linkage that makes it possible

The operational backbone is straightforward, and it is the sort of thing that is trivial to set up on day one and miserable to retrofit at volume:

  1. Assign a unique batch ID at inbound receiving. Every shipment that arrives from a supplier gets one, before anything is shelved.
  2. Link that ID to the supplier COA, the invoice, and your own test results. One record, three documents, permanently associated.
  3. Record which batch ID was picked at fulfillment, per order. This is the step everyone skips, and it is the only one that actually connects a lot to a human being.

Get those three right and the recall question becomes a query. Miss the third and you have excellent inbound records that cannot tell you who has the product.

The benchmark to build against

There is no research-peptide-specific traceability regulation to comply with. What exists is a useful benchmark from an adjacent regulated category: the FDA's FSMA 204 framework, formally a food rule, expects critical tracking event records to be producible within 24 hours of an inquiry.

That is the standard worth designing to, not because it binds you, but because it is a reasonable articulation of what “we have traceability” should mean in practice. If someone asks and you need a week, you do not have traceability. You have paperwork.

What it gets you besides recall

Recall readiness is the reason to build it. It is not the only return.

What to write down before you need it

The records are only half of it. The other half is having decided, in advance, what you will do:

Writing this once, calmly, produces far better decisions than improvising it during the event. It is also the artifact that demonstrates you run an operation rather than a storefront, which matters to processors, suppliers and serious customers for different reasons.

The honest argument for doing it early

Nobody builds traceability because they are excited about it. It gets built after a scare, or not at all.

The case for doing it at the start is simply that the cost curve is brutal. Assigning batch IDs and recording them at pick is nearly free when you are shipping ten orders a day. Reconstructing lot history across thousands of historical orders, from supplier invoices and shipping records that were never designed to be joined, is a project you will not want to fund at the moment you most need the answer.

In a category where supply quality genuinely varies between suppliers and between shipments from the same supplier, assuming you will never need to answer the question is not a plan.

Quality documentation is underwriting documentation

COAs, SOPs, and lot control all appear in a high-risk merchant application. Here is the complete file processors work from.

Get the Payment-Approval Checklist (PDF) →

Keep reading

→ The five-element COA every research buyer checks → Cold chain for lyophilized peptides: moisture, not heat → What your processor needs before they will approve you → Research-use-only compliance basics

This guide is general information, not legal advice. FSMA 204 is a food-safety framework referenced here as an operational benchmark, not a regulation applicable to research peptides. Recall obligations and record-keeping requirements depend on your products and jurisdiction; consult qualified counsel when designing a recall procedure.